These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 177190)

  • 1. Combination chemotherapy with 5-fluorouracil (NSC-19893), methotrexate (NSC-740), and prednisolone (NSC-9900) (FAP protocol) for hepatoma.
    Umsawasdi T; Chainuvati T; Hitannant S; Nilprabhassorn P; Viranuvatti V
    Cancer Chemother Rep; 1975; 59(6):1167-9. PubMed ID: 177190
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination chemotherapy with methotrexate (NSC-740), adriamycin (NSC-123127), cyclophosphamide (NSC-26271), and 5-fluorouracil (NSC19893) for adult solid tumors.
    Stephens RL; Hoogstraten B
    Cancer Chemother Rep; 1974; 58(6):943-5. PubMed ID: 4614901
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination chemotherapy with 5--fluorouracil, amethopterin (methotrexate) and prednisolone (FAP protocol) in the therapy of cholangiocarcinoma.
    Umsawasdi T; Chainuvati T; Hitanant S; Nilprabhassorn P; Viranuvatti V
    J Med Assoc Thai; 1976 Aug; 59(8):380-3. PubMed ID: 184225
    [No Abstract]   [Full Text] [Related]  

  • 4. Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study.
    Baker LH; Saiki JH; Jones SE; Hewlett JS; Brownlee RW; Stephens RL; Vaitkevicius VK
    Cancer Treat Rep; 1977 Nov; 61(8):1595-7. PubMed ID: 200359
    [No Abstract]   [Full Text] [Related]  

  • 5. Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma.
    Cochrane AM; Murray-Lyon IM; Brinkley DM; Williams R
    Cancer; 1977 Aug; 40(2):609-14. PubMed ID: 196734
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination chemotherapy with cyclophosphamide (NSC-26 271), methotrexate (NSC-740), and prednisolone (NSC-9 900) (CMP protocol), for metastatic breast cancer.
    Umsawasdi T; Nilprabhassorn P
    J Med Assoc Thai; 1978 Mar; 61(3):158-61. PubMed ID: 660008
    [No Abstract]   [Full Text] [Related]  

  • 7. A pilot study of sequential combination chemotherapy with adriamycin and cyclophosphamide, and methotrexate, 5-fluorouracil and prednisolone in advanced breast cancer.
    Collis CH
    Br J Clin Pract; 1978 May; 32(5):139-44. PubMed ID: 666968
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic approaches to hepatoma.
    Falkson G
    Cancer Treat Rev; 1975 Mar; 2(1):73-6. PubMed ID: 171068
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical studies in Asian patients with irresectible primary hepatocellular carcinoma treated by adriamycin and prednisolone alone or in combination with 5-fluorouracil, vincristine and prednisolone.
    Singapore Med J; 1978 Dec; 19(4):192-204. PubMed ID: 220733
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic results using VP 16-213 alone or in combination with 5-fluorouracil in liver cancer (hepatoma)].
    Cavalli F; Tschopp L; Gerber A; Sonntag RW; Ryssel HJ; Brunner KW
    Schweiz Med Wochenschr; 1977 Dec; 107(52):1960-6. PubMed ID: 202020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infusion chemotherapy in hepatoma and metastatic liver tumors.
    Gorgun B; Watne AL
    Am J Surg; 1967 Mar; 113(3):363-8. PubMed ID: 4289539
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of primary liver cancer: response to regional chemotherapy.
    Wellwood JM; Cady B; Oberfield RA
    Clin Oncol; 1979 Mar; 5(1):25-31. PubMed ID: 217565
    [No Abstract]   [Full Text] [Related]  

  • 13. [Apropos of a hepatoma: rôle of regional chemotherapy].
    Bessot M; Thevenin F; Fays J; Grilliat JP
    Sem Hop; 1968 Jun; 44(29):1995-6. PubMed ID: 4299982
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chemotherapy of inoperable breast cancer with a combination of 5-fluorouracil, methotrexate, vincristine, cyclophosphamide and prednisolone].
    Raevskiĭ IG
    Sov Med; 1976 Aug; (8):112-4. PubMed ID: 1006408
    [No Abstract]   [Full Text] [Related]  

  • 15. Preliminary clinical trials of dichloromethotrexate (NSC-29630) in hepatocellular carcinoma.
    Vogel CL; Adamson RH; DeVita VT; Johns DG; Kyalwazi SK
    Cancer Chemother Rep; 1972 Apr; 56(2):249-58. PubMed ID: 4339634
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of the toxicity of precautional chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in carcinoma of the breast in the first 700 treatment cycles].
    Sismondi P; Zola P; Galletto L; De Giovanni D; Giardina G
    Minerva Ginecol; 1979; 31(7-8):563-8. PubMed ID: 481814
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II trial of 5-fluorouracil (NSC-19893), adriamycin (NSC-123127), and methotrexate (NSC-740) in lung adenocarcinoma.
    Lowitz BB
    Cancer Treat Rep; 1976 May; 60(5):623-4. PubMed ID: 991153
    [No Abstract]   [Full Text] [Related]  

  • 18. Dihydropyrimidine dehydrogenase activity in hepatocellular carcinoma: implication in 5-fluorouracil-based chemotherapy.
    Jiang W; Lu Z; He Y; Diasio RB
    Clin Cancer Res; 1997 Mar; 3(3):395-9. PubMed ID: 9815697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infusion of liver tumours.
    Br Med J; 1968 Aug; 3(5614):329. PubMed ID: 4298665
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
    Mouridsen HT; Palshof T
    Prog Clin Biol Res; 1977; 12():459-66. PubMed ID: 335404
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.